David Siffert, legal director at S.T.O.P., discusses 23andMe’s possible bankruptcy along with the potential legal fallout and the privacy threat it poses to our genetic data.

Thomson Reuters will pay out a $27.5 million settlement to people whose information was exposed by its Clear AI product, but the window to opt-in closes at the end of this week on Dec. 27.

It remains unknown how many patients are affected by the incident. The Qilin ransomware group claims to have leaked 400 gigabytes of sensitive data allegedly stolen from Synnovis, including patient names, health system registration numbers, and descriptions of blood tests.

Amy Nordrum, executive editor, and Charlotte Jee, news editor. Each year, MIT Technology Review publishes an annual list of the top ten breakthrough technologies that will have the greatest impact on how we live and work in the future.

What happens in the US, however, will depend a lot on the incoming Trump administration. Vertical farms, woke AI, and 23andMe made our annual list of failed tech. Rapid advances in applying artificial intelligence to simulations in physics and chemistry ...

Two of the most popular brands are Ancestry and 23andMe. To learn more, we outlined the pros, cons and factors to consider. However, since this comparison was first published, 23andMe has ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

Now, an alliance between Novartis and genetic testing specialist 23andMe is trying to encourage greater awareness of Lp(a) and improve testing rates. The pilot programme will see a confidential ...